Concerning effects on tumor growth, the precise role of SPRY2 in CRC remains controversial as one study has reported SPRY2 functions as a tumor suppressor [18], whereas our previous studies have suggested SPRY2 might function as an oncogene by promoting EMT [13,14,15]. The gene discussed is SPRY2; the disease is colorectal carcinoma.